Followers | 130 |
Posts | 14996 |
Boards Moderated | 1 |
Alias Born | 06/04/2018 |
![](https://investorshub.advfn.com/uicon/675392.png?cb=1562414338)
Wednesday, November 04, 2020 1:45:23 PM
Image source: The Motley Fool. Supernus Pharmaceuticals Inc (NASDAQ: SUPN) Q3 2020 Earnings Call Nov 4, 2020 , 9:00 a.m. ET Operator Continue reading For further details see: Supernus Pharmaceuticals Inc (SUPN) Q3 2020 Earnings Call Trans...
Read the whole news SUPN - Supernus Pharmaceuticals Inc (SUPN) Q3 2020 Earnings Call Transcript
@whytestocks
Recent SUPN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 11:03:01 AM
- Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA • GlobeNewswire Inc. • 08/19/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:18:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:16:00 PM
- Supernus Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 08:16:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:58:35 PM
- Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device • GlobeNewswire Inc. • 08/01/2024 08:30:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:19:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/31/2024 08:41:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 08:02:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/29/2024 08:08:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/24/2024 08:48:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:20:54 PM
- Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 • GlobeNewswire Inc. • 07/23/2024 08:13:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 08:24:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/19/2024 08:28:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:18:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:14:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:10:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:05:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/15/2024 08:53:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/17/2024 09:15:42 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM